CN103611181A - 一种抗菌肽水凝胶及其制备方法 - Google Patents
一种抗菌肽水凝胶及其制备方法 Download PDFInfo
- Publication number
- CN103611181A CN103611181A CN201310517751.6A CN201310517751A CN103611181A CN 103611181 A CN103611181 A CN 103611181A CN 201310517751 A CN201310517751 A CN 201310517751A CN 103611181 A CN103611181 A CN 103611181A
- Authority
- CN
- China
- Prior art keywords
- antibacterial peptide
- hydrogel
- peptide
- polysaccharide polymer
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 43
- 239000000017 hydrogel Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000005017 polysaccharide Substances 0.000 claims abstract description 17
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 16
- 238000011065 in-situ storage Methods 0.000 claims abstract description 7
- 229920000642 polymer Polymers 0.000 claims abstract description 7
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 17
- -1 polyethylene Polymers 0.000 claims description 16
- 150000004804 polysaccharides Chemical class 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 14
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 12
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 12
- 229920002674 hyaluronan Polymers 0.000 claims description 12
- 229960003160 hyaluronic acid Drugs 0.000 claims description 12
- 239000004698 Polyethylene Substances 0.000 claims description 11
- 229920000573 polyethylene Polymers 0.000 claims description 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 10
- 239000002861 polymer material Substances 0.000 claims description 10
- 229920001038 ethylene copolymer Polymers 0.000 claims description 9
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 6
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 6
- 239000005977 Ethylene Substances 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 239000004964 aerogel Substances 0.000 claims description 5
- 239000012620 biological material Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 229920001451 polypropylene glycol Polymers 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 230000008542 thermal sensitivity Effects 0.000 claims description 5
- 102000005600 Cathepsins Human genes 0.000 claims description 4
- 108010084457 Cathepsins Proteins 0.000 claims description 4
- 229920000615 alginic acid Polymers 0.000 claims description 4
- 235000010443 alginic acid Nutrition 0.000 claims description 4
- 239000000893 inhibin Substances 0.000 claims description 4
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 229920001503 Glucan Polymers 0.000 claims description 3
- 101710180399 Glycine-rich protein Proteins 0.000 claims description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 102100028262 U6 snRNA-associated Sm-like protein LSm4 Human genes 0.000 claims description 3
- 239000000783 alginic acid Substances 0.000 claims description 3
- 229960001126 alginic acid Drugs 0.000 claims description 3
- 150000004781 alginic acids Chemical class 0.000 claims description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 229960004793 sucrose Drugs 0.000 claims description 3
- 229960003487 xylose Drugs 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 2
- 230000000845 anti-microbial effect Effects 0.000 claims 2
- 206010052428 Wound Diseases 0.000 abstract description 17
- 208000027418 Wounds and injury Diseases 0.000 abstract description 17
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 6
- 230000029663 wound healing Effects 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 208000032544 Cicatrix Diseases 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 231100000241 scar Toxicity 0.000 abstract 1
- 230000037387 scars Effects 0.000 abstract 1
- 238000004904 shortening Methods 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- POIUWJQBRNEFGX-XAMSXPGMSA-N cathelicidin Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C1=CC=CC=C1 POIUWJQBRNEFGX-XAMSXPGMSA-N 0.000 description 9
- 241001597008 Nomeidae Species 0.000 description 7
- 238000004007 reversed phase HPLC Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 230000021615 conjugation Effects 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
- 102000013275 Somatomedins Human genes 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 108700022109 ropocamptide Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 108060001132 cathelicidin Proteins 0.000 description 2
- 102000014509 cathelicidin Human genes 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000007039 two-step reaction Methods 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102400000669 Antibacterial peptide LL-37 Human genes 0.000 description 1
- 101800000245 Antibacterial peptide LL-37 Proteins 0.000 description 1
- 108010050820 Antimicrobial Cationic Peptides Proteins 0.000 description 1
- 102000014133 Antimicrobial Cationic Peptides Human genes 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 108010019494 Histatins Proteins 0.000 description 1
- 102000006492 Histatins Human genes 0.000 description 1
- 229920001231 Polysaccharide peptide Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010057040 Temperature intolerance Diseases 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008543 heat sensitivity Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000036457 multidrug resistance Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 108010022457 polysaccharide peptide Proteins 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Images
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310517751.6A CN103611181B (zh) | 2013-10-25 | 2013-10-25 | 一种抗菌肽水凝胶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310517751.6A CN103611181B (zh) | 2013-10-25 | 2013-10-25 | 一种抗菌肽水凝胶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103611181A true CN103611181A (zh) | 2014-03-05 |
CN103611181B CN103611181B (zh) | 2015-06-17 |
Family
ID=50161912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310517751.6A Active CN103611181B (zh) | 2013-10-25 | 2013-10-25 | 一种抗菌肽水凝胶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103611181B (zh) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103536960A (zh) * | 2013-10-30 | 2014-01-29 | 无锡灵锡医疗器械科技有限公司 | 一种可缓释抗菌肽的水凝胶及其制备方法 |
CN106512064A (zh) * | 2017-01-12 | 2017-03-22 | 广东泰宝医疗器械技术研究院有限公司 | 一种具有抗菌性能的皮肤创伤敷料及其制备方法 |
CN106540238A (zh) * | 2016-11-03 | 2017-03-29 | 东南大学 | 一种自组装抗菌脂肽纳米银颗粒及其制备方法 |
CN106963727A (zh) * | 2017-06-01 | 2017-07-21 | 国械(上海)贸易有限公司 | 包含玻尿酸和抗菌肽的硅凝胶祛疤修复产品及其制备方法 |
CN108525003A (zh) * | 2018-03-13 | 2018-09-14 | 中山大学 | 基于酰腙键和亲疏水自组装的双交联杂化水凝胶、其制备方法及皮肤组织创面修复剂 |
CN108904868A (zh) * | 2018-08-13 | 2018-11-30 | 安徽创孚医疗科技有限公司 | 一种双联抗菌及抗凝敷料的制备方法 |
CN109106979A (zh) * | 2018-09-11 | 2019-01-01 | 吉林省蓝鼎陆和科技有限公司 | 一种十三肽抗菌敷料及其制备方法 |
CN109157669A (zh) * | 2018-09-18 | 2019-01-08 | 东华大学 | 纤维素增强葡聚糖基可注射抗菌水凝胶敷料及其制备方法 |
CN110876815A (zh) * | 2019-12-30 | 2020-03-13 | 壹齐生物科技(广州)有限公司 | 一种负载富血小板血浆和抗菌肽的水凝胶及其制备方法和应用 |
CN110876814A (zh) * | 2019-07-07 | 2020-03-13 | 青岛惠诺德生物科技有限公司 | 一种富含抗菌肽的液体创可贴及其制备方法 |
CN111388741A (zh) * | 2020-04-01 | 2020-07-10 | 东华大学 | 预载多肽的可注射自修复抗菌水凝胶敷料及其制备方法 |
CN112263708A (zh) * | 2020-11-02 | 2021-01-26 | 上海交通大学 | 一种促进创面愈合的多功能气凝胶敷料及其制备方法 |
CN112316203A (zh) * | 2020-11-06 | 2021-02-05 | 黄石瀚海新材料科技有限公司 | 阳离子抗菌肽和透明质酸复合水凝胶及其制备方法 |
CN112933290A (zh) * | 2021-02-22 | 2021-06-11 | 宿烽 | 一种水凝胶及其在制备治疗伤口的制品中的应用 |
CN113069412A (zh) * | 2021-03-31 | 2021-07-06 | 浙江大学 | 一种用于皮肤创伤修复的可注射复合壳聚糖水凝胶的制备方法 |
CN113181422A (zh) * | 2021-05-18 | 2021-07-30 | 四川轻化工大学 | 一种抑菌无毒水凝胶敷料及其制备方法 |
CN116763720A (zh) * | 2023-06-06 | 2023-09-19 | 广州图微科创生物科技有限公司 | 一种多肽自组装水凝胶及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2504259A1 (en) * | 2002-12-03 | 2004-06-17 | Novartis Ag | Medical devices having antimicrobial coatings thereon |
CN1729014A (zh) * | 2002-12-19 | 2006-02-01 | 希尔曼·伊兹查克 | 通过抗菌肽抑制剂治疗疾病的方法 |
CN1899264A (zh) * | 2006-07-20 | 2007-01-24 | 上海交通大学 | 温度敏感型水凝胶释药体系及其制备方法 |
CN101177487A (zh) * | 2006-11-08 | 2008-05-14 | 天津大学 | 温敏性可生物降解聚酸酐共聚物及其水凝胶体系和应用 |
CN101720237A (zh) * | 2007-06-25 | 2010-06-02 | 利波佩普蒂德有限公司 | 新型医用产品 |
US20100278894A1 (en) * | 2009-04-30 | 2010-11-04 | Medtronic, Inc. | Antioxidants and antimicrobial accessories including antioxidants |
CN101914561A (zh) * | 2010-07-13 | 2010-12-15 | 广东药学院 | 一种具有抗菌和修复功能的融合蛋白及其生产方法和应用 |
-
2013
- 2013-10-25 CN CN201310517751.6A patent/CN103611181B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2504259A1 (en) * | 2002-12-03 | 2004-06-17 | Novartis Ag | Medical devices having antimicrobial coatings thereon |
CN1729014A (zh) * | 2002-12-19 | 2006-02-01 | 希尔曼·伊兹查克 | 通过抗菌肽抑制剂治疗疾病的方法 |
CN1899264A (zh) * | 2006-07-20 | 2007-01-24 | 上海交通大学 | 温度敏感型水凝胶释药体系及其制备方法 |
CN101177487A (zh) * | 2006-11-08 | 2008-05-14 | 天津大学 | 温敏性可生物降解聚酸酐共聚物及其水凝胶体系和应用 |
CN101720237A (zh) * | 2007-06-25 | 2010-06-02 | 利波佩普蒂德有限公司 | 新型医用产品 |
US20100278894A1 (en) * | 2009-04-30 | 2010-11-04 | Medtronic, Inc. | Antioxidants and antimicrobial accessories including antioxidants |
CN101914561A (zh) * | 2010-07-13 | 2010-12-15 | 广东药学院 | 一种具有抗菌和修复功能的融合蛋白及其生产方法和应用 |
Non-Patent Citations (2)
Title |
---|
LILIANA S. MOREIRA TEIXEIRA ET AL.: "Enzyme-catalyzed crosslinkable hydrogels: Emerging strategies for tissue engineering", 《BIOMATERIALS》, vol. 33, no. 5, 26 November 2011 (2011-11-26), pages 1281 - 1290, XP028339082, DOI: doi:10.1016/j.biomaterials.2011.10.067 * |
TAICHI ITO ET AL.: "Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone", 《BIOMATERIALS》, vol. 28, no. 10, 3 January 2007 (2007-01-03), pages 1778 - 1786, XP005856374, DOI: doi:10.1016/j.biomaterials.2006.12.012 * |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103536960A (zh) * | 2013-10-30 | 2014-01-29 | 无锡灵锡医疗器械科技有限公司 | 一种可缓释抗菌肽的水凝胶及其制备方法 |
CN106540238A (zh) * | 2016-11-03 | 2017-03-29 | 东南大学 | 一种自组装抗菌脂肽纳米银颗粒及其制备方法 |
CN106540238B (zh) * | 2016-11-03 | 2021-02-26 | 东南大学 | 一种自组装抗菌脂肽纳米银颗粒及其制备方法 |
CN106512064B (zh) * | 2017-01-12 | 2019-12-10 | 广东泰宝医疗器械技术研究院有限公司 | 一种具有抗菌性能的皮肤创伤敷料及其制备方法 |
CN106512064A (zh) * | 2017-01-12 | 2017-03-22 | 广东泰宝医疗器械技术研究院有限公司 | 一种具有抗菌性能的皮肤创伤敷料及其制备方法 |
CN106963727A (zh) * | 2017-06-01 | 2017-07-21 | 国械(上海)贸易有限公司 | 包含玻尿酸和抗菌肽的硅凝胶祛疤修复产品及其制备方法 |
CN108525003A (zh) * | 2018-03-13 | 2018-09-14 | 中山大学 | 基于酰腙键和亲疏水自组装的双交联杂化水凝胶、其制备方法及皮肤组织创面修复剂 |
CN108904868A (zh) * | 2018-08-13 | 2018-11-30 | 安徽创孚医疗科技有限公司 | 一种双联抗菌及抗凝敷料的制备方法 |
CN109106979A (zh) * | 2018-09-11 | 2019-01-01 | 吉林省蓝鼎陆和科技有限公司 | 一种十三肽抗菌敷料及其制备方法 |
CN109157669A (zh) * | 2018-09-18 | 2019-01-08 | 东华大学 | 纤维素增强葡聚糖基可注射抗菌水凝胶敷料及其制备方法 |
CN109157669B (zh) * | 2018-09-18 | 2021-02-23 | 东华大学 | 纤维素增强葡聚糖基可注射抗菌水凝胶敷料及其制备方法 |
CN110876814A (zh) * | 2019-07-07 | 2020-03-13 | 青岛惠诺德生物科技有限公司 | 一种富含抗菌肽的液体创可贴及其制备方法 |
CN110876815A (zh) * | 2019-12-30 | 2020-03-13 | 壹齐生物科技(广州)有限公司 | 一种负载富血小板血浆和抗菌肽的水凝胶及其制备方法和应用 |
CN111388741A (zh) * | 2020-04-01 | 2020-07-10 | 东华大学 | 预载多肽的可注射自修复抗菌水凝胶敷料及其制备方法 |
CN111388741B (zh) * | 2020-04-01 | 2021-09-07 | 东华大学 | 预载多肽的可注射自修复抗菌水凝胶敷料及其制备方法 |
CN112263708A (zh) * | 2020-11-02 | 2021-01-26 | 上海交通大学 | 一种促进创面愈合的多功能气凝胶敷料及其制备方法 |
CN112263708B (zh) * | 2020-11-02 | 2021-09-28 | 上海交通大学 | 一种促进创面愈合的多功能气凝胶敷料及其制备方法 |
CN112316203A (zh) * | 2020-11-06 | 2021-02-05 | 黄石瀚海新材料科技有限公司 | 阳离子抗菌肽和透明质酸复合水凝胶及其制备方法 |
CN112933290A (zh) * | 2021-02-22 | 2021-06-11 | 宿烽 | 一种水凝胶及其在制备治疗伤口的制品中的应用 |
CN112933290B (zh) * | 2021-02-22 | 2022-05-06 | 宿烽 | 一种水凝胶及其在制备治疗伤口的制品中的应用 |
CN113069412A (zh) * | 2021-03-31 | 2021-07-06 | 浙江大学 | 一种用于皮肤创伤修复的可注射复合壳聚糖水凝胶的制备方法 |
CN113181422A (zh) * | 2021-05-18 | 2021-07-30 | 四川轻化工大学 | 一种抑菌无毒水凝胶敷料及其制备方法 |
CN116763720A (zh) * | 2023-06-06 | 2023-09-19 | 广州图微科创生物科技有限公司 | 一种多肽自组装水凝胶及其制备方法 |
CN116763720B (zh) * | 2023-06-06 | 2023-12-12 | 广州图微科创生物科技有限公司 | 一种多肽自组装水凝胶及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103611181B (zh) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103611181B (zh) | 一种抗菌肽水凝胶及其制备方法 | |
CN103536960B (zh) | 一种可缓释抗菌肽的水凝胶及其制备方法 | |
Talikowska et al. | Application of conducting polymers to wound care and skin tissue engineering: A review | |
MacLeod et al. | The innate immune system in acute and chronic wounds | |
Qi et al. | Progress in hydrogels for skin wound repair | |
Moura et al. | Recent advances on the development of wound dressings for diabetic foot ulcer treatment—A review | |
Loo et al. | Ultrashort peptide nanofibrous hydrogels for the acceleration of healing of burn wounds | |
Lei et al. | Antimicrobial hydrogel microspheres for protein capture and wound healing | |
Wiegand et al. | Polymer‐based biomaterials as dressings for chronic stagnating wounds | |
CN110559476B (zh) | 一种含有肽类抗炎活性成分的液体创可贴及其制备方法 | |
CN104710511B (zh) | 一种源于带鱼鱼肉蛋白的铁螯合肽及其制备方法和用途 | |
JP5979673B2 (ja) | タンパク質水溶液 | |
EP1694370B1 (en) | Wound care products containing keratin | |
CN101412753A (zh) | 金环蛇抗菌肽cathelicidin-BF及其基因和应用 | |
Yu et al. | Antibacterial conductive self-healable supramolecular hydrogel dressing for infected motional wound healing | |
CN113214507B (zh) | 一种抗菌糖肽水凝胶的制备方法 | |
Liu et al. | A pressure-resistant zwitterionic skin sensor for domestic real-time monitoring and pro-healing of pressure injury | |
CN110066321A (zh) | 一种抗菌水凝胶及其制备方法和应用 | |
Banerjee et al. | Fabrication of in situ layered hydrogel scaffold for the co-delivery of PGDF-BB/chlorhexidine to regulate proinflammatory cytokines, growth factors, and MMP-9 in a diabetic skin defect albino rat model | |
CN113563419B (zh) | 一种促皮肤创伤修复活性同源二聚体多肽及其制备方法与应用 | |
CN109157669A (zh) | 纤维素增强葡聚糖基可注射抗菌水凝胶敷料及其制备方法 | |
Yang et al. | Injectable polylysine and dextran hydrogels with robust antibacterial and ROS-scavenging activity for wound healing | |
Zhang et al. | An extracellular matrix-inspired self-healing composite hydrogel for enhanced platelet-rich plasma-mediated chronic diabetic wound treatment | |
Dinescu et al. | Efficiency of multiparticulate delivery systems loaded with flufenamic acid designed for burn wound healing applications | |
Choi et al. | Amniotic membrane extract-loaded double-layered wound dressing: evaluation of gel properties and wound healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170602 Address after: Jinniu District Jin Fang Yuan Road Chengdu 610000 Sichuan province No. 8 5 Building 2 unit 4 Building No. 8 Patentee after: Liu Zhigang Address before: Xishan Economic Development Zone, Jiangsu province 214192 Technology Park in Wuxi city (three Furong Road No. 99) cloud five Patentee before: WUXI LINGXI MEDICAL DEVICES TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220523 Address after: Room 8, floor 4, unit 2, building 5, No. 8, Jinfangyuan West Road, Jinniu District, Chengdu, Sichuan 610036 Patentee after: Liu Zhongyi Address before: Room 8, floor 4, unit 2, building 5, No. 8, Jinfangyuan West Road, Jinniu District, Chengdu, Sichuan 610000 Patentee before: Liu Zhigang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220725 Address after: 610041 No. 21, floor 4, block B, building 1, Incubation Park, No. 1480, north section of Tianfu Avenue, high tech Zone, Chengdu, Sichuan Province Patentee after: Chengdu Haizhuo paite Technology Co.,Ltd. Address before: Room 8, floor 4, unit 2, building 5, No. 8, Jinfangyuan West Road, Jinniu District, Chengdu, Sichuan 610036 Patentee before: Liu Zhongyi |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240227 Address after: No. 1888 Huanhu East Road, Dongjiageng Town, Dongdong New District, Chengdu City, Sichuan Province, 610000 Patentee after: Sichuan Haizhuopate Technology Co.,Ltd. Country or region after: China Address before: 610041 No. 21, floor 4, block B, building 1, Incubation Park, No. 1480, north section of Tianfu Avenue, high tech Zone, Chengdu, Sichuan Province Patentee before: Chengdu Haizhuo paite Technology Co.,Ltd. Country or region before: China |